Showing posts with label Replacement. Show all posts
Showing posts with label Replacement. Show all posts

Who Is More Prone To Develop Colorectal Cancer?

The exact reason why colon cancer develops in some persons and not in others is not clear. The incidence of colon cancer is quite varied among different countries and within different ethnic groups inside the same country. Industrialized countries like United States, Canada, UK, Western Europe, Australia and Japan have a much higher incidence of colorectal cancer compared to the less industrialized parts of the world like Asia, Africa, and South America. Colorectal cancer represent over 9 percent of all cancers in men and about 10 percent of all cancers in women world-wide. In industrialized countries the incidence of colorectal cancer can be as high as 12 to 14 of all cancers, and in non-industrialized countries much lower rates of about 7 to 8 percent of all cancers diagnosed may be colorectal cancer.

Excluding skin cancer, colorectal cancer is the third commonest cancer diagnosed in the United States. Each year over 100,000 Americans are diagnosed with colon cancer and over 50 percent of these patients will die from colorectal cancer. Colon cancer incidence is not much different between males and females, however colon cancer is slightly more prevalent in women compared to men (ratio of 1.2:1) but the rectal cancer is more common in males (ratio of 1.7:1).

Even though we do not know the exact cause of development of colorectal cancer, scientists have recognized several factors that can increase the risk of development of colorectal cancer. A risk factor for a disease is any condition that makes a person more likely to develop that diseases. Some of the risk factors like dietary factors are modifiable by the person involved while some other factors like age are un-modifiable. These risk factors may act in combination, and this combination of risk factors may be associated with cumulative increase in the risk of development of colorectal cancer. The simple presence of one or more risk factors does not necessarily mean that someone will develop colorectal cancer. On the other hand absence of all risk factors does not mean that an individual will not develop colorectal cancer, but generally more risk factors you have higher is the chance of developing colorectal cancer. Environmental factors also may be playing a role in the development of colorectal cancer. People who migrate from areas of low risk to areas of the world with higher risk of developing colorectal cancer, they tend to acquire the risk of the country to which they are migrating. This finding suggests the presence of environmental factors causing higher risk of developing colorectal cancer. Changes in dietary factors associated with migration may also be contributing to this increase in risk associated with migration from low risk areas to higher risk areas.

Risk factors for the development of colorectal cancer include the following:

Age over 50 years
Increased fat intake
Large intestinal polyps
Family history of colon cancer
Inflammatory bowel diseases like ulcerative colitis and Crohn's disease.
Personal history of other cancers
Sedentary habits and lack of exercise
Obesity
Diabetes
Smoking
Alcohol content
Genetic colon cancer syndromes like Familial adenomatous polyposis or Hereditary Non-polyposis Colon Cancer (HNPCC)

Persons who have high risk of colorectal cancer may undergo screening for colorectal cancer with colonoscopy once every 2 to 3 years. Screening colonoscopy is recommended for every one who is 50 years or older. If someone has a higher than average risk of developing colorectal cancer, the screening may be initiated earlier than 50 years.

Weight lifting Workouts Birth injury

Continuar leyendo

IBS Medications - Ways to Treat Irritable Bowel Syndrome

IBS medications are symptom-specific which means that they try to reduce such symptoms as constipation, painful abdominal spasms and diarrhea. If the first IBS drug that you try does not help in symptom reduction, then go on to another option.

Research into functional disorders affecting the small intestine and colon (for example, IBS) is more difficult to conduct and there is less agreement among the research studies. This probably is a reflection of the complexity of the activities of the small intestine and colon and the difficulty in studying these activities. Researchers discover that patients who have at least one first degree relative with colon cancer were 25% less likely to die from the disease during 5.6 years of follow-up than those with no close relatives with colon cancer. The risk of dying was even lower (51%) for those with two or more relatives with colon cancer.

Treatment with these drugs does not address the cause of your IBS, and once you stop using the drugs the symptoms will return. The use of these drugs often results in serious side effects and/or negative long-term consequences. Treatment with lubiprostone showed significantly higher rates of gastrointestinal adverse events, especially diarrhea and nausea. These results warrant further study of lubiprostone for treatment of IBS-C patients. Treatment for irritable bowel syndrome (IBS) usually involves long-term management of your symptoms. It is important that you have a good working relationship with your health professional to monitor your symptoms and identify changes in your diet and lifestyle that can help relieve the symptoms.

Keep trying ibs medication until you find one that works for you.

Regional Medical Center Generic home health care

Continuar leyendo